2008: Vasculitis I
Search or Browse by Day

Vasculitis I

Sunday, October 26, 2008
607
Separation of Organ Specificity in a Murine Model of Vasculitis By Modification Of Isolation and Purification Of Lactobacillus Casei Cell Wall Extracts
608
Novel Autoantigen For Anti-endothelial Cell Antibodies (AECA) Identified by Proteomics In Systemic Vasculitis
609
Association Of Il-18 Gene Polymorphism With Susceptibility To Biopsy-proven Giant Cell Arteritis
610
Increased Serum Interleukin 17 in Patients with Active Giant Cell Arteritis
611
Th17 Cells as Mediators of Vessel Wall Damage in Giant Cell Arteritis
612
Correlation of MMP-2, -9 and -12 Expression with Temporal Artery Histopathologic Findings
613
Functional Assessment of the Role of Interferon Gamma (IFNγ) in Giant-Cell Arteritis (GCA)
614
Does the Extent of Temporal Artery Duplex Ultrasound Findings Correlate With Ophthalmic Complications in Giant Cell Arteritis?
615
Association Between Histological Parameters in Temporal Artery Biopsies and Clinical Features of Patients with Giant Cell Arteritis
616
Colour Doppler Sonography Should Precede Temporal Artery Biopsy in the Diagnose of Giant Cell Arteritis
617
Adhesion Molecules Expression and Chemotactic Ability of Peripheral Blood Leukocytes In Polymyalgia Rheumatica and Giant Cell Arteritis
618
Circulating Cytokines in Active Polymyalgia Rheumatica/Giant Cell Arteritis: Influence of Corticosteroid Therapy
619
Administration Of Steroids Prior To Temporal Artery Biopsy : Effects On Biopsy Results. The Prospective, Multicenter GRACG Study
620
Sensitivity, Specificity, Positive And Negative Predictive Values Of PMR Diagnostic Criteria: The GRACG Study
621
Small Vessel Vasculitis : A Diagnostic Marker For PMR ? The GRACG Study
622
Risk Factors for Severe Cranial Ischemic Events in Giant Cell Arteritis
623
Prognosis of Large-Vessel Giant Cell Arteritis
624
Long-Term Outcomes of Patients with Giant Cell Arteritis Enrolled in a Clinical Trial of Methotrexate Treatment
625
C-Reactive Protein 3872G/A Polymorphism in Giant Cell Arteritis
626
Association of Temporal Artery Calcifications with Visual Loss in Giant Cell Arteritis
627
In-Hospital Mortality and Cardiovascular Outcomes in Giant Cell Arteritis
628
Outcome Of Aortic Structural Damage (ASD) After Long-term Follow-up Of Patients With Giant-cell Arteritis (GCA). Cross-sectional Screening Of 19 Prospectively Followed Patients
629
Occurrence of Takayasu Arteritis in the United Kingdom
630
Juvenile Onset Takayasu Arteritis: Poor Prognosis and Refractory Disease
631
High Frequency of Lipoprotein Risk Levels for Cardiovascular Disease in Takayasu Arteritis
632
The utility of 18F-FDG PET in Takayasu arteritis
633
Cardiovascular Risk Factors and Acute Phase Response in Idiopathic Ascending Aortitis- A Case Control Study
634
Large-vessel Vasculitis Pattern in Patients with Chronic Periaortitis
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>